Rekombinanter Bevacizumab Antikörper (Biotin)
Reaktivität: Human
Wirt: Maus
Monoclonal
AY13
Biotin
Recombinant Antibody
-
- Target Alle Bevacizumab Produkte
- Bevacizumab
- Antikörpertyp
- Recombinant Antibody
- Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser Bevacizumab Antikörper ist konjugiert mit Biotin
- Verwendungszweck
- Biotinylated Anti-Bevacizumab Antibody (AY13) (recommended for PK/PD)
- Produktmerkmale
- Anti-idiotypic Antibodies
- Immunogen
- Mouse monoclonal antibody is produced from a hybridoma resulting from fusion of SP2/0 myeloma and B-lymphocytes obtained from a mouse immunized with Bevacizumab F(ab')2.
- Klon
- AY13
-
-
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Lagerung
- -20 °C
-
- Target
- Bevacizumab
- Abstract
- Bevacizumab Produkte
- Substanzklasse
- Antibody
- Hintergrund
- A recombinant humanized monoclonal IgG1 antibody that binds to and inhibits the biologic activity of human vascular endothelial growth factor (VEGF). Bevacizumab contains human framework regions and the complementarity-determining regions of a murine antibody that binds to VEGF. Bevacizumab is produced in a Chinese Hamster Ovary mammalian cell expression system in a nutrient medium containing the antibiotic gentamicin and has a molecular weight of approximately 149 kilodaltons.
-
Sie sind hier:
